BioSpace News Archive

Seed Health, a microbiome science company pioneering innovations in probiotics, today announced the publication of a double-blind, placebo-controlled clinical study in Pediatric Research (Nature Portfolio) –– the official journal of the American Pediatric Society, the European Society for Paediatric Research, and the Society for Pediatric Research.

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (“FDA”) for leuprolide acetate for injection.

Lantern Pharma Inc. today announced that Lantern management will be presenting at two upcoming investor conferences.

Twist Bioscience Corporation and Illumina, Inc. today announced a partnership to provide expanded customer access to the co-branded Twist Bioscience ® for Illumina ® Exome 2.0 Plus panel designed to advance disease research.

Sonnet BioTherapeutics Holdings, Inc. announced today that the safety of SON-1010 dosing in several cohorts has been formally reviewed in both Phase 1 clinical trials and that dose escalation is continuing as early data becomes available.

Astria Therapeutics, Inc., a biopharmaceutical company developing STAR-0215 for the treatment of hereditary angioedema and focused on life-changing therapies for rare and niche allergic and immunological diseases, granted stock options to purchase 46,500 shares of Astria’s common stock on November 1, 2022 under Astria’s 2022 Inducement Stock Incentive Plan.

Inscopix, Inc. announced that it is expanding the market availability for its Inscopix Data Exploration, Analysis and Sharing Platform to include individual labs, which allows academic researchers to vastly improve how they share, analyze and organize neuroscience data.

Equillium, Inc. today announced that it has initiated a Phase 1 study of EQ102 in healthy volunteers.

Inogen, Inc. today announced financial results for the quarter ended September 30, 2022, and provided a business update.

Medical Manufacturing Technologies (MMT) announced the purchase of Confluent Medical Technologies’ equipment manufacturing group, which includes their balloon forming equipment manufacturing as well as their testing and catheter manufacturing equipment capabilities.